James A Merritt Net Worth & Insider Trades

James A Merritt - President & Chf Med Officer, Adventrx Pharmaceuticals Inc

As of December 17, 2007

What is James A Merritt's Net Worth?

The current estimated net worth of Adventrx Pharmaceuticals Inc's President & Chf Med Officer, James A Merritt, is estimated to be about $15.5K . James A Merritt owns about 35,000 units of Adventrx Pharmaceuticals Inc common stock. In the last 12 months at Adventrx Pharmaceuticals Inc, James A Merritt has sold an estimated value of $0 worth.

What is James A Merritt's Past Insider Trading?

James A Merritt's largest purchase order was 30,000 units , worth over $13.28K on December 17, 2007. In total, James A Merritt has made about 2 transactions over 12 months of their time at Adventrx Pharmaceuticals Inc. James A Merritt usually trades in December and January, with the busiest year in 2007.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

James A Merritt

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Adventrx Pharmaceuticals Inc's Past Insider Trades?

Adventrx Pharmaceuticals Inc's most recent insider trade came on May 14, 2012 by David A Ramsay who bought 50,000 units worth $26.96K . In the last 7 years, insiders at Adventrx Pharmaceuticals Inc have sold an estimated value of $535.49K and bought an estimated value of $589.07K worth of shares. Insider trading is most common in July, with the busiest year in 2006. The most active traders at the company are Brian M Culley, CEO and Director,  Patrick L Keran, President & COO,  and Evan Levine, CEO & President .

ADVENTRX PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...